Skip to main content

Cormorant Asset Management, LP

Position in CRNX — Crinetics Pharmaceuticals, Inc.

CIK 1583977 BOSTON, MA

Position in CRNX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,677,500
-$4,402,500 QoQ
Shares Held
125,000
-50.0% QoQ
Ownership
0.118%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#72
of 266 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CRNX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Cormorant Asset Management, LP holds $1,889,506,429 across 46 Biotechnology names. CRNX ranks #37 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CRNX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,677,500 125,000
2026-03-31 $9,080,000 250,000
2025-12-31 $13,965,000 300,000
2025-09-30 $16,660,000 400,000
2025-06-30 $11,504,000 400,000
2025-03-31 $20,124,000 600,000
2024-12-31 $51,130,000 1,000,000
2024-09-30 $56,210,000 1,100,000
2024-06-30 $60,466,500 1,350,000
2024-03-31 $53,831,500 1,150,000
2023-12-31 $40,917,000 1,150,000
2023-09-30 $32,770,624 1,101,904